Balyasny Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,454
| Closed | -$189K | – | 2547 |
|
|
2025
Q1 | $189K | Buy |
34,454
+17,301
| +101% | +$95K | ﹤0.01% | 1824 |
|
|
2024
Q4 | $58.1K | Buy |
+17,153
| New | +$58.1K | ﹤0.01% | 1836 |
|
|
2022
Q2 | – | Sell |
-109,305
| Closed | -$280K | – | 2754 |
|
|
2022
Q1 | $280K | Buy |
109,305
+89,877
| +463% | +$230K | ﹤0.01% | 1593 |
|
|
2021
Q4 | $57K | Buy |
+19,428
| New | +$57K | ﹤0.01% | 1812 |
|